Considerations for Analytical Characterisation of Antibody- Oligonucleotide Conjugates

2:15 pm - Wednesday 10th March 2027

  • Developing analytical tools for antibody-oligonucleotide conjugates and overcoming the challenges for characterisation method development
  • Determining the exact oligonucleotideto-antibody ratio (OAR) and similarity to to DAR challenges in ADCs
  • Measuring intact AOC and overcoming challenges with structural complexity, charge variants and aggregation

Speakers:

Senior Director, Analytical Development & Quality Control
Dyne Therapeutics